A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction
The serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)
W. Brian Gibler, MD,
James W. Hoekstra, MD,
W. Douglas Weaver, MD,
Mitchell W. Krucoff, MD,
Alfred P. Hallstrom, PhD,
Raymond E. Jackson, MD,
Michael R. Sayre, MD,
James Christenson, MD,
George L. Higgins, MD,
Grant Innes, MD,
Richard J. Harper, MD,
Gary P. Young, MD,
Nathan R. Every, MD for the SMARTT Investigators*